C12N 2770/28141
Use of virus, viral particle or viral elements as a vector
C12N2770/28141 (Use of virus, viral particle or viral elements as a vector) appears on 6 US grants and 10 published applications in this corpus.
Search patents in C12N- Granted patents
- 6
- Published applications
- 10
- Assignees
- 10
- Inventors
- 18
- Latest grant
- 21 Aug 2018
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2012 | 0 | 2 |
| 2013 | 0 | 1 |
| 2014 | 2 | 0 |
| 2015 | 1 | 1 |
| 2016 | 0 | 1 |
| 2017 | 2 | 1 |
| 2018 | 1 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 0 |
| 2026 | 0 | 2 |
By publication year. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12N 2770/28142Virus or viral particle as vehicleIndexing code4
- C12N 2770/28143Viral genome or elements thereof as genetic vectorIndexing code2
- C12N 2770/28144Chimeric viral vector comprising heterologous viral elements for production of another viralIndexing code0
- C12N 2770/28145Special targeting system for viral vectorsIndexing code0
Recent patents
- Chemically activated nanocapsid functionalized for cancer targeting21 Aug 2018US 10,053,494 B2The Regents of the University of California
- Infectious hepatitis E virus genotype 3 recombinants26 Dec 2017US 9,850,468 B2Royal Cornwall Hospital Trust
- Proteolysis-resistant capsid of chimeric hepatitis E virus as an oral delivery vector2 May 2017US 9,637,524 B2The Regents of the University of California
- Infectious hepatitis E virus genotype 3 recombinants10 Nov 2015US 9,181,530 B2Royal Cornwall Hospital Trust
- Multiple antigen delivery system using hepatitis E virus-like particle9 Dec 2014US 8,906,862 B2National Institute of Infectious Disease
- Hepatitis e virus-like particles (vlps) derived from consensus sequences10 Sep 2026US 2026/0263379 A1Novo Capsid Technologies LLC
- Virus-like nanocapsid for oral delivery of insulin11 Jun 2026US 2026/0159817 A1The Regents of the University of California
- Virus-like nanocapsid for oral delivery of insulin11 Feb 2021US 2021/0038697 A1The Regents of the University of California
- Chemically activated nanocapsid functionalized for cancer targeting31 Jan 2019US 2019/0031720 A1The Regents of the University of California
- Chemically Activated Nanocapsid Functionalized for Cancer Targeting20 Apr 2017US 2017/0107261 A1The Regents of the University of California
Most cited
By later US patents